tradingkey.logo

KORU Medical Systems Inc

KRMD
4.920USD
+0.050+1.03%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
227.76MMarktkapitalisierung
VerlustKGV TTM

KORU Medical Systems Inc

4.920
+0.050+1.03%

mehr Informationen über KORU Medical Systems Inc Unternehmen

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc Informationen

BörsenkürzelKRMD
Name des UnternehmensKORU Medical Systems Inc
IPO-datumOct 27, 1993
CEOTharby (Linda M)
Anzahl der mitarbeiter80
WertpapierartOrdinary Share
GeschäftsjahresendeOct 27
Addresse100 Corporate Drive
StadtMAHWAH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07430
Telefon18454692042
Websitehttps://www.korumedical.com/
BörsenkürzelKRMD
IPO-datumOct 27, 1993
CEOTharby (Linda M)

Führungskräfte von KORU Medical Systems Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+29463.00%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
+300000.00%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
94.10K
+2581.00%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
91.47K
+2581.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
91.11K
+2581.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+26904.00%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
44.27K
+2581.00%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+29463.00%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
+300000.00%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
94.10K
+2581.00%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
91.47K
+2581.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
91.11K
+2581.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+26904.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Domestic Core
6.12M
58.86%
International Core
3.70M
35.53%
Novel Therapies
584.27K
5.62%
Nach RegionUSD
Name
Umsatz
Anteil
Domestic
6.71M
64.47%
International
3.70M
35.53%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Domestic Core
6.12M
58.86%
International Core
3.70M
35.53%
Novel Therapies
584.27K
5.62%

Aktionärsstatistik

Aktualisiert: Thu, Feb 5
Aktualisiert: Thu, Feb 5
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.77%
Tharby (Linda M)
4.58%
Andere
60.33%
Aktionäre
Aktionäre
Anteil
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.77%
Tharby (Linda M)
4.58%
Andere
60.33%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
22.17%
Investment Advisor
17.32%
Investment Advisor/Hedge Fund
16.24%
Individual Investor
8.54%
Pension Fund
0.84%
Research Firm
0.33%
Bank and Trust
0.10%
Insurance Company
0.01%
Andere
34.45%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
179
26.41M
57.01%
-1.20M
2025Q3
175
25.43M
54.99%
-237.14K
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Horton Capital Management LLC
5.87M
12.68%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.53M
9.77%
-153.89K
-3.29%
Sep 30, 2025
Topline Capital Management, LLC
3.65M
7.88%
+39.89K
+1.11%
Sep 30, 2025
The Vanguard Group, Inc.
2.15M
4.63%
+60.11K
+2.88%
Sep 30, 2025
Tharby (Linda M)
2.12M
4.58%
+29.46K
+1.41%
Oct 16, 2025
BlackRock Institutional Trust Company, N.A.
1.93M
4.17%
+266.62K
+16.00%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.01M
2.17%
+9.65K
+0.97%
Sep 30, 2025
Meros Investment Management, LP
848.90K
1.83%
-1.49K
-0.18%
Sep 30, 2025
Empire Financial Management Company, LLC
824.53K
1.78%
+824.53K
--
Sep 30, 2025
Archon Capital Management LLC
700.15K
1.51%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Mehr Anzeigen
iShares Micro-Cap ETF
Anteil0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.03%
iShares Russell 2000 ETF
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0%
DFA Dimensional US Sustainability Core 1 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI